Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycycline, and minocycline with in vivo use
- PMID: 947710
- DOI: 10.1159/000221939
Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycycline, and minocycline with in vivo use
Abstract
Susceptibility of 983 isolates of Staphyloccus aureus to tetracycline, doxycycline and minocycline was determined in vitro. Minocycline was shown to be more active than doxycycline, which in turn was shown to be slightly more active than tetracycline. 77% of the isolates which were resistant to tetracycline were also resistant to doxycycline, whereas only 4% of the tetracycline-resistant isolates were resistant to minocycline. The in vivo use of tetracycline correlated with increased in vitro resistance of S. aureus to tetracycline and doxycycline. A correlation between use of tetracycline and in vitro resistance to minocycline was not demonstrated.
Similar articles
-
[Comparative activity of tetracycline, doxycycline and minocycline against Haemophilus].Pathol Biol (Paris). 1983 May;31(5):413-8. Pathol Biol (Paris). 1983. PMID: 6353333 French.
-
Letter: Effect of minocycline on tetracycline-resistant Staphylococcus aureus.Lancet. 1974 May 18;1(7864):1006. doi: 10.1016/s0140-6736(74)91335-x. Lancet. 1974. PMID: 4133636 No abstract available.
-
Evaluation of minocycline susceptibility of methicillin-resistant Staphylococcus pseudintermedius.Vet Microbiol. 2013 Mar 23;162(2-4):968-971. doi: 10.1016/j.vetmic.2012.10.002. Epub 2012 Oct 11. Vet Microbiol. 2013. PMID: 23107659
-
Minocycline and Doxycycline: More Than Antibiotics.Curr Mol Pharmacol. 2021;14(6):1046-1065. doi: 10.2174/1874467214666210210122628. Curr Mol Pharmacol. 2021. PMID: 33568043 Review.
-
Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature.Clin Infect Dis. 2005 May 15;40(10):1429-34. doi: 10.1086/429628. Epub 2005 Apr 6. Clin Infect Dis. 2005. PMID: 15844065 Review.
Cited by
-
Novel Collagen Membrane Formulations with Irinotecan or Minocycline for Potential Application in Brain Cancer.Materials (Basel). 2024 Jul 15;17(14):3510. doi: 10.3390/ma17143510. Materials (Basel). 2024. PMID: 39063802 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources